Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: The potential role
β Scribed by Mona Saraiya; Marc T. Goodman; S. Deblina Datta; Vivien W. Chen; Phyllis A. Wingo
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 216 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
TABLE 1 Results From an Ad Hoc Meeting Conducted by the Pan American Health Organization on Important Biologic Endpoints for Human Papillomavirus Vaccine Surveillance Endpoints for HPV Surveillance and Measurement Indicators Endpoint Measurement Indicator Genital HPV infections Changes in prevalence Genital warts (depends on vaccine product being used) Changes in prevalence Cervical cancer precursors, specifically CIN-3 based on histologic determination Changes in the overall prevalence Invasive cervical cancer based on histologic determination Changes in the incidence profiles Invasive cervical cancer mortality Changes in mortality profiles HPV type-specific changes in histologically defined CIN-3 lesions Changes in type-specific incidence in CIN-3 precursor lesions HPV indicates human papillomavirus; CIN-3, cervical intraepithelial neoplasia grade 3.
π SIMILAR VOLUMES
## Abstract Head and neck cancer is the world's sixth most common cancer, but despite advances in treatment, there has been no significant decline in the mortality rate. In recent years, there has been mounting epidemiologic and experimental evidence of a role for human papillomavirus (HPV) as the
## Abstract The aim of this study was to determine the proportion of invasive cervical cancers attributable to human papillomavirus (HPV) types 16 and 18 in a contemporary, cytologically wellβscreened UK population. This was achieved in a retrospective observational analysis by HPV typing 453 archi